Evaluation of routinely collected records for dementia outcomes in UK: a prospective cohort study

被引:5
|
作者
Hayat, Shabina [1 ]
Luben, Robert [2 ,3 ,4 ]
Khaw, Kay-Tee [2 ]
Wareham, Nicholas [2 ]
Brayne, Carol [1 ]
机构
[1] Univ Cambridge, Dept Psychiat, Cambridge, England
[2] MRC Epidemiol Unit, Cambridge, England
[3] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England
[4] UCL Inst Ophthalmol, London, England
来源
BMJ OPEN | 2022年 / 12卷 / 06期
基金
英国医学研究理事会;
关键词
Dementia; PUBLIC HEALTH; EPIDEMIOLOGY; PRIMARY-CARE; DIAGNOSIS;
D O I
10.1136/bmjopen-2022-060931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To evaluate the characteristics of individuals recorded as having a dementia diagnosis in different routinely collected records and to examine the extent of overlap of dementia coding across data sources. Also, to present comparisons of secondary and primary care records providing value for researchers using routinely collected records for dementia outcome capture. Study design A prospective cohort study. Setting and participants A cohort of 25 639 men and women in Norfolk, aged 40-79 years at recruitment (1993-1997) followed until 2018 linked to routinely collected to identify dementia cases. Data sources include mortality from death certification and National Health Service (NHS) hospital or secondary care records. Primary care records for a subset of the cohort were also reviewed. Primary outcome measure Diagnosis of dementia (any-cause). Results Over 2000 participants (n=2635 individuals) were found to have a dementia diagnosis recorded in one or more of the data sources examined. Limited concordance was observed across the secondary care data sources. We also observed discrepancies with primary care records for the subset and report on potential linkage-related selection bias. Conclusions Use of different types of record linkage from varying parts of the UK's health system reveals differences in recorded dementia diagnosis, indicating that dementia can be identified to varying extents in different parts of the NHS system. However, there is considerable variation, and limited overlap in those identified. We present potential selection biases that might occur depending on whether cause of death, or primary and secondary care data sources are used. With the expansion of using routinely collected health data, researchers must be aware of these potential biases and inaccuracies, reporting carefully on the likely extent of limitations and challenges of the data sources they use.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank
    Mccracken, Celeste
    Raisi-Estabragh, Zahra
    Szabo, Liliana
    Veldsman, Michele
    Raman, Betty
    Topiwala, Anya
    Roca-Fernandez, Adriana
    Husain, Masud
    Petersen, Steffen E.
    Neubauer, Stefan
    Nichols, Thomas E.
    [J]. BMJ EVIDENCE-BASED MEDICINE, 2024,
  • [2] Effect of trazodone on cognitive decline in people with dementia: Cohort study using UK routinely collected data
    Sommerlad, Andrew
    Werbeloff, Nomi
    Perera, Gayan
    Smith, Tanya
    Costello, Harry
    Mueller, Christoph
    Kormilitzin, Andrey
    Broadbent, Matthew
    Nevado-Holgado, Alejo
    Lovestone, Simon
    Stewart, Robert
    Livingston, Gill
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 37 (01)
  • [3] SEVERITY OF DEMENTIA AT DEATH: COHORT STUDY USING ROUTINELY COLLECTED SECONDARY CARE DATA
    Aworinde, J.
    Werbeloff, N.
    Lewis, G.
    Livingston, G.
    Sommerlad, A.
    [J]. AGE AND AGEING, 2018, 47
  • [4] Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK
    Cooksey, Roxanne
    Kennedy, Jonathan
    Dennis, Michael S.
    Escott-Price, Valentina
    Lyons, Ronan A.
    Seaborne, Michael
    Brophy, Sinead
    [J]. PLOS ONE, 2020, 15 (09):
  • [5] The use of routinely collected healthcare records for outcome assessment in clinical trials: a UK perspective
    Sathyanarayanan, Abilash
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (05) : 887 - 892
  • [6] Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study
    Alimam, Samah
    Bewley, Susan
    Chappell, Lucy C.
    Knight, Marian
    Seed, Paul
    Gray, Gabriella
    Harrison, Claire
    Robinson, Susan
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (01) : 31 - 36
  • [7] The validity of dementia diagnoses in routinely collected electronic health records in the United Kingdom: A systematic review
    McGuinness, Luke A.
    Warren-Gash, Charlotte
    Moorhouse, Louisa R.
    Thomas, Sara L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (02) : 244 - 255
  • [8] Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial
    Baptiste, Paris J.
    Wong, Angel Y. S.
    Schultze, Anna
    Cunnington, Marianne
    Mann, Johannes F. E.
    Clase, Catherine
    Leyrat, Clemence
    Tomlinson, Laurie A.
    Wing, Kevin
    [J]. BMJ OPEN, 2022, 12 (03):
  • [9] Use of routinely collected data from electronic health records for outcomes in NIHR HTA trials
    Mckay, Andrew J.
    Farmer, Andrew J.
    Gamble, Carrol
    Jones, Ashley P.
    Williamson, Paula R.
    [J]. TRIALS, 2019, 20
  • [10] The association between atrial fibrillation and dementia: A UK linked electronic health records cohort study
    Brooks, Kieran
    Yoshimura, Hiroyuki
    Gonzalez-Izquierdo, Arturo
    Zakkak, Nadine
    Kukendra-Rajah, Kishore
    Lip, Gregory Y. H.
    Providencia, Rui
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (05)